Business Unit
Research & Development
DSIR-approved R&D Centre driving innovation in APIs, intermediates, formulations and process improvement for complex molecules.
R&D Centre Highlights
- R&D Centre approved by DSIR (Dept. of Scientific & Industrial Research, Govt. of India)
- World-class set up for development of APIs, Intermediates & Process Improvement of complex molecules
- Chemical R&D, Formulation R&D, Analytical R&D (Oncology & Non-Oncology products)
- Gas Chromatography, FTIR, HPLC, LCMS, UV, Combiflash, Particle Size Analyser, Rota evaporator
- Dedicated Stability Chambers for accelerated stability studies, Photostability and various Zones
- Latest formulation R&D scale equipment: RMG, FBD, Roller Compactor, Coater in Isolator, Lyophiliser, Liquid injection filling machine, Walk-in Fuming Hoods
R&D Centre: API Capabilities
SRL has experienced and dedicated teams of scientists committed towards innovation in new process development with focus on:
- Development of non-infringing processes for generic APIs
- Cost optimization
Our team is capable of:
- High potent APIs handling in OEB 3 & 4 levels in Dynamic / Static Isolators
- AR&D facility with glove box static isolators for sample analysis
- Development of Environment Friendly processes
- Development of Chiral APIs and economically viable processes
R&D Chemistry Capabilities: Catalytic Hydrogenations, Organoborane Chemistry, Chiral Synthesis and Resolutions, Grignard reactions, Acylations and alkylation, Organometallic (LDA/ Alkyl Lithium), Carbon Homologation.
Chemical & Analytical Research Capabilities
Team is supported by state-of-the-art Chemical & Analytical Research capabilities to develop:
- Method Validation
- Impurity profiling and assessment
- Synthesis, Isolation and Characterization of Impurities
- Expertise in Organometallic reactions sustainable for commercial manufacturing
- Handling sensitive pyrophoric reagents & cryogenic reactions
- Ability to comply with ICH guidelines
- Coupling Reactions, Aminations, Nitration, Diazotisation, Reductions, Halogenations, Cyanation
Formulation Capabilities
- State-of-the-art formulation & analytical development supported by Regulatory Services, IP Management, QA & Project Management
- Full support from Concept to commercialisation
- CDMO model offering end-to-end services till commercialization
- Formulation strategy based on IP Landscape, Scientific literature, CQA and QTPP study
Formulation Development – Dosage Forms
Capsules
- Powder/granules, Pellets (IR, ER and SR)
- Modified release – beads or mini tablets in capsules
- MUPS (Multiple Unit Particle Systems)
Semi Solids
- Gels, Creams, Ointments
Liquid
- Syrup, Elixir
Injectable
- Solutions, Suspensions, Emulsions
Novel Drug Delivery
- Liposome, Niosome, Microsphere, Nano-emulsion, Nano-liposomes
Buccal Delivery
- ODF/ODS/OF
